USA flag logo/image

An Official Website of the United States Government

Search


Download to spreadsheetPrint
Displaying 76 – 100 of 9023 Awards
Company: AURITEC PHARMACEUTICALS, INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): The broad long-term of this project is to develop methods for evaluation of adherence to intravaginal microbicide therapy for the prevention of HIV transmission. Correct determination of adherence to preventative therapies in clinical trials is essential to… more
Company: AURITEC PHARMACEUTICALS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): The long term goal of this project is to prevent HIV transmission. Using the drug delivery platform we developed for the ganciclovir intraocular implant, Vitrasert(R), we propose to develop an intravaginal ring microbicide formulation… more
Company: AURITEC PHARMACEUTICALS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): The broad long-term goal of this research is to reduce morbidity due to arthritis by developing long-lasting injectable intra-articular drug delivery systems. Intra-articular steroids have been a mainstay of treatment for arthritis for more… more
Company: TERAPIO Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … to septicemia, increasinghospital stays and costs, and ultimately discontinuation of radiotherapy. This impacts overall effectiveness of cancer therapy so development of an agent for prevention and treatment of OM is clearly an unmet need. Terapio is developing a drug,… more
Company: AVANTGEN, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … a panel of synapse proteins, many of which have been shown to be modulated in response to opiate administration. In this Phase I/II study, antibodies against a panel of about 150 synaptic proteins will be developed and used to probe the changes of these proteins upon drug… more
Company: AXION BIOSYSTEMS, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … liquid handling, user-friendly experiment tools, and sophisticated neural analysis software. For scientists, this integration will significantly improve their ability to extact functional information from neural cultures; paving the way for new progress in drug discovery… more
Company: BCR DIAGNOSTICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: …. Milestone: Data showing sensitivity and specificity near 100%. Phase II plan: To convert the biosensor into a marketable prototype for research and clinical laboratories, and to use the prototype for a study designed to obtain 510 (k) clearance from the Food and Drug… more
Company: BEXION PHARMACEUTICALS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … glioblastoma multiforme (GBM, high grade glioma), a deadly and invasive brain tumor with no effective treatment. Of the 12,000 patients expected to be diagnosed with GBM this year, most will succumb within a year. There is an urgent demand for an efficacious anti-glioma drug.… more
Company: BIOSENSE TECHNOLOGIES, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): Resistance to chemotherapeutic drugs is an ongoing problem that results in eventual treatment failures or suboptimal patient outcomes. Approximately one-quarter of BCR-ABL(+) leukemia patients demonstrate evidence of resistance to imatinib… more
Company: BOLDER BIOTECHNOLOGY, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: … bone marrow cells to divide and differentiate into neutrophils. Recombinant human G-CSF is widely used to treat chemotherapy-related neutropenia in cancer patients, and recent studies indicate that it improves overall survival in animal models of ARS, although the drug… more
Company: Boulder Nonlinear Systems, Inc. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: …de-offs in manufacturability and cost to develop a variable custom manufacturing process that would including everything from simple marking to 3-D imaging using lens arrays or even constructing full holograms. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: Counterfeit … more
Company: CFD Research Corporation Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … used for both treatment of lung diseases (such as asthma and chronic obstructive pulmonary disease) and in delivering drugs to the systemic circulation. To reach the desired effectiveness and safety oforally/nasally inhaled drugs, appropriate deposition of drugs on… more
Company: CHARLESSON, LLP Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … including VEGF, TNF- , ICAM-1 and CTGF, and inhibits multiple pathological processes of DR such as retinal vascular leakage, inflammation and neovascularization. Based on these observations, we hypothesize that 2F1mab has great potential to become an effective drug for… more
Company: ChromoLogic LLC Agency/Program/Year/Phase: DOD / SBIR / 2013 / 1
Abstract: … coatings on aircraft carriers, naval ships, and submarines. In the civilian market, CIMOSA could used to detect oxidative corrosion in coatings on commercial airplanes and automobiles, detection of false coatings on counterfeit electrical components, counterfeit drug… more
Company: CLINICAL TOOLS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … people reported using prescription pain medications (opioids) non-medically (without a prescription) [1], and 2 million people reported using prescription painkillers non-medically for thefirst time [1]. In 2009, 1/3 o people older than 12 initiated illicit drug use via… more
Company: CLINICAL TOOLS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … by applicant) An epidemic of addiction to prescription pain medications now causes deaths due to overdose that outnumber automobile-related deaths, rising admissions to hospitals, and disrupted lives for both the patient and family.The White House Office of National Drug… more
Company: AC DIAGNOSTICS, INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: … with HIV, with 96% residing in the developing world. While antiretroviral therapy is effective and increasingly available, the standard of care requires periodic monitoring of patients' viral load to individualize treatment and to control the emergence and spread of drug-… more
Company: COGNOSCI, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … population. Work Plan Overview: To translate COG1410 to the clinic and reduce the risks associated with commercialization (please see details in the attached proposal), we are proposing to perform allstudies necessary to receive approval of an Investigational New Drug (IND)… more
Company: COLBY PHARMACEUTICAL COMPANY Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: Oral mucositis is a major complication of radiotherapy for the treatment of head and neck cancer and a major dose-limiting side effect. Our work has shown that intra-esophageal administration of plasmidlliposomes containing the transgene expressing humansuperoxide dismutase 2 (SOD2) (JVRSOD) … more
Company: Compact Membrane Systems, Inc. Agency/Program/Year/Phase: DOE / SBIR / 2013 / 1
Abstract: … in collaboration with the group of Professor Robin Rogers at the University of Alabama, will develop new technology for the acid catalyzed conversion of the plant-derived sugar sorbitol to isosorbide, a diol of interest as a chemical intermediate, pharmaceutical… more
Company: Compact Membrane Systems, Inc. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION: Summary Enhanced Recovery of Pharmaceutical Solvent driven by EPA Initiative Recent Events: On July 6, 2011 the United States Environmental Protection Agency (EPA) announced plans to establish new safeguards for hazardous secondary materialsrecycling with… more
Company: Giner Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … equipment and to achieve size, performance and safety advantages over existing technologies. Phase I will assess overall feasibility of concept by focusing on design of MOX reactor and identifying requirements to inactivate selection of highly used pharmaceutical … more
Company: CORSOLUTIONS, LLC Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): The merging of cell culture and microfluidic technology has resulted in improved in vitro models for toxicity studies, drug development, and biomedical research. The reason for which microfluidic approaches provide a more accurate in vitro… more
Company: SAI INTERACTIVE, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: …. In more than one-third ofED visits, patients are unable to provide an accurate list of their medications. Discrepancies and other errors in the documented medication list affect diagnostic and treatment decisions in the ED, and increase the risk of harmful adverse drug… more
Company: ROCKLAND IMMUNOCHEMICALS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: … conjugated with chelators for radiolabeling with metal radionuclides. Pharmacokinetic, pharmacodynamics, immunogenic and toxicological characteristics of agents will be investigated in animal models to obtain data necessary for filing an Investigational New Drug application.… more
Displaying 76 – 100 of 9023 Awards
Narrow Your Search
By Agency
By Year
By Phase
By Program
By State
By Company Ownership
By Company
HELP FOR NARROW YOUR SEARCH

Search Options

There are several categories such as “By Agency”, “By Year”, “By State” etc. Select a checkbox within a category to refine your search results.

Each of your selections is listed in the “Narrow Search Filters” bar. You can uncheck these selections to remove them.


Search for Either Criteria

When you select multiple values within a category, the results will include values that match either of the selections. For example, selecting “2005” and “2007” in the “By Year” category will display results that include either 2005 OR 2007 in the results.


Narrowing the Search Results

You can refine your search results across categories. To narrow down your results, select multiple values across different categories. The results will only include values that match the selections across the categories. For example, selecting “2005” in the “By Year” category and “NASA” in the “By Agency” category will only display the results that contain both “2005” AND “NASA” in the results.